Effect of chronic kidney disease in ischemic cardiomyopathy: Long-term follow-up - REVISION-DM2 trial.
Hueb, Thiago Ovanessian; Lima, Eduardo Gomes; Rocha, Mauricio S; Siqueira, Sergio F; Nishioka, Silvana Angelina Dório; Peixoto, Giselle L; Saccab, Marcos M; Garcia, Rosa Maria Rahmi; Ramires, José Antonio F; Kalil Filho, Roberto; Martinelli Filho, Martino.
; 98(12): e14692, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30896618
Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidatesâ©.
ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study.
Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.
Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.
Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.
Epidemiology of comorbidities in patients with hypertension.
Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty-A study from a tertiary care center in South India.
Prevalence, clinical predictors, and prognostic impact of chronic renal insufficiency in very old Chinese patients with coronary artery disease.